This Wednesday Mar 2, The Lesbian and Gay Community Center of Charlotte is partnering with the McColl Center for Visual Art to bring a showing of “Orgasm Inc.”, a flavorful and risky documentary on the pharmaceutical industry’s attempt to problematize female sexuality. This partnership was able to snag an excellent pre-theatre release screening in Charlotte – an unlikely feat for any non-profit organization – as the Lesbian and Gay Community Center’s own board member and McColl staff member Delvin McNeil is actually featured in the documentary. So big props to director Liz Canner and the distributors of Orgasm Inc. for allowing Charlotteans the special chance to view this important production!
Below is a short synopsis from the film’s website, http://orgasminc.org:
In the shocking and hilarious documentary ORGASM INC., filmmaker Liz Canner takes a job editing erotic videos for a drug trial for a pharmaceutical company. Her employer is developing what they hope will be the first Viagra drug for women that wins FDA approval to treat a new disease: Female Sexual Dysfunction (FSD). Liz gains permission to film the company for her own documentary. Initially, she plans to create a movie about science and pleasure but she soon begins to suspect that her employer, along with a cadre of other medical companies, might be trying to take advantage of women (and potentially endanger their health) in pursuit of billion dollar profits. ORGASM INC. is a powerful look inside the medical industry and the marketing campaigns that are literally and figuratively reshaping our everyday lives around health, illness, desire — and that ultimate moment: orgasm.
Upbeat, engaging, enlightening, and provocative,
ORGASM INC. will change the way you think about sex.
Interested in attending? Tickets are only $7 and can be purchased at the door or online at www.gaycharlotte.com. The film begins at 7 p.m. Then let us know what you think! Email your likes, dislikes, or questions about the film to email@example.com for a chance to have your opinions included in a review piece soon to follow the screening.